Epsilon M&A Deal Report - Orphan Europe
Transaction Multiples for the Valuation of Private Companies
Recordati / Orphan Europe
No EMAT :
18542
Announced Date :
27/09/2007
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Recordati
Target :
Orphan Europe
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Orphan Europe SARL, a pharmaceutical company , engages in developing, producing, packaging, and distributing drugs for the treatment of rare and orphan diseases . Its products include Normosang,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 29/06/2006 | Spacelabs Healthcare | Del Mar Reynolds Medical | England | * | 17938 |
| 10/11/2006 | Private Group led by nSpire Health LLC | Respiratory Division of Ferraris Group | United Kingdom | * | 17937 |
Source: Epsilon Research / EMAT
